Skip to Content

What type of drug is Yescarta (axicabtagene ciloleucel)?

Responses (1)

Official Answer by 8 Nov 2017

Yescarta (axicabtagene ciloleucel), from Kite Pharma/Gilead is a chimeric antigen receptor T cell (CAR T) therapy used for adults with large B-cell lymphoma after failing at least two other treatments. The patient’s T-cells, a type of white blood cell, are genetically modified and reinfused to target lymphoma cancer cells. It is a type of gene therapy and was FDA-approved in October 2017. CAR T therapy is manufactured specifically for each individual patient and is considered a breakthrough in hematologic cancer treatment.

Specifically, Yescarta was approved in adult patients with large B-cell lymphoma after at least two other kinds of treatment failed. Lymphoma types approved for treatment include diffuse large B-cell lymphoma (DLBCL), primary mediastinal large B-cell lymphoma, high grade B-cell lymphoma and DLBCL arising from follicular lymphoma. Yescarta is not indicated for the treatment of patients with primary central nervous system lymphoma. free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Similar Questions

Drug Name on Medical I.D. Tag?

Posted 29 Dec 2012 6 answers

What is the difference between Rituxan and Rituxan Hycela?

Posted 5 Jul 2017 1 answerFAQ by

What is the cost of Yescarta?

Posted 8 Nov 2017 1 answerFAQ by

How is Yescarta administered?

Posted 8 Nov 2017 1 answerFAQ by